Journal
LANGENBECKS ARCHIVES OF SURGERY
Volume 406, Issue 8, Pages 2643-2655Publisher
SPRINGER
DOI: 10.1007/s00423-021-02201-0
Keywords
Intraductal papillary mucinous neoplasm; Intraductal oncocytic papillary neoplasm; Intraductal tubulopapillary neoplasm; Pathology; Pancreatic cancer; Pancreas cancer
Categories
Ask authors/readers for more resources
Informed clinical decisions in the treatment of Intraductal Papillary Mucinous Neoplasms (IPMNs) are based on a deep understanding of the pathology of these lesions, with a focus on balancing the risk of over treatment with the patient's best interests.
Background Intraductal papillary mucinous neoplasms (IPMNs) represent a unique opportunity to treat and prevent a curable neoplasm before it has the chance to progress to incurable cancer. This prospect, however, has to be balanced with the real risk of over treating patients with lesions that would, in fact, never progress during the life of the patient. Purpose Informed clinical decisions in the treatment of IPMNs are first and foremost based on a deep understanding of the pathology of these lesions. Conclusions Here we review the pathology of IPMNs, with an emphasis on the clinical relevance of the important features that characterize these lesions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available